KREMEN2 and gastric cancer: Kremen2 activates the PI3K/AKT pathway in gastric cancer, and the knockdown of Kremen2 decreases total PI3K and AKT proteins [10], which, in turn, prevents AKT-mediated p53 degradation [37] but promotes apoptosis.